Cargando…
Evolution of IL-23 Blockade in Inflammatory Bowel Disease
Autores principales: | Danese, Silvio, Peyrin-Biroulet, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097673/ https://www.ncbi.nlm.nih.gov/pubmed/35553668 http://dx.doi.org/10.1093/ecco-jcc/jjab188 |
Ejemplares similares
-
Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022) -
Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise
por: Danese, Silvio, et al.
Publicado: (2021) -
Adaptive Designs: Lessons for Inflammatory Bowel Disease Trials
por: D’Amico, Ferdinando, et al.
Publicado: (2020) -
Inflammatory Bowel Diseases and COVID-19: The Invisible Enemy
por: D’Amico, Ferdinando, et al.
Publicado: (2020) -
Can we change the natural course of inflammatory bowel
disease?
por: Le Berre, Catherine, et al.
Publicado: (2023)